Brief: Windlas Biotech Concludes EU GMP Inspection, Received Zero Critical Observations
April 14 (Reuters) - Windlas Biotech Ltd WINL.NS :
* CONCLUDES EU GMP INSPECTION, RECEIVED ZERO CRITICAL
OBSERVATIONS/ DEFICIENCIES
Source text for Eikon: ID:nBSEbJDZk9
Further company coverage: WINL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windlas Biotech
See all newsBrief: Windlas Biotech Approves Buyback Of Shares Worth Up To 470 Million Rupees
Brief: Windlas Biotech Dec-Quarter Consol Net Profit 150 Million Rupees
Brief: Windlas Biotech June-Quarter Consol Net Profit 176.6 Million Rupees
Brief: Windlas Biotech Gets GMP Certification For New Injectable Facility
Brief: Windlas Biotech June-Quarter Consol Net Profit 134.8 Mln Rupees